ArriVent Biopharma, Inc. Contracts & Agreements

23 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
ArriVent Biopharma, Inc.
2025
Exclusive License Agreement, dated January 21, 2025, by and between Lepu Biopharma Co., Ltd and the Registrant
License Agreements
ArriVent Biopharma, Inc.
2025
Amended and Restated Research Collaboration Agreement between Aarvik Therapeutics, Inc. and ArriVent BioPharma, Inc.
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Research and Collaboration Agreement Between Jiangsu Alphamab Biopharmaceuticals Co., Ltd and Arrivent Biopharma, Inc
Collaboration Agreements
ArriVent Biopharma, Inc.
NY
2024
Description of Securities
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Executive Severance Plan
Severance Agreements
ArriVent Biopharma, Inc.
DE
2024
2024 Employee, Director and Consultant Equity Incentive Plan, form of stock option agreement and form of restricted stock agreement thereunder
Bonus & Incentive Agreements
ArriVent Biopharma, Inc.
DE
2024
Form of Underwriting Agreement
Underwriting Agreements
ArriVent Biopharma, Inc.
2024
License Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated June 29, 2021, as amended by Amendment No. 1, dated November 6, 2023
License Agreements
ArriVent Biopharma, Inc.
DE
2024
Clinical Collaboration Agreement, by and between the Registrant and Beijing InnoCare Pharma Tech Co., Ltd., dated June 23, 2023
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Research Collaboration Agreement, dated December 21, 2021, by and between Aarvik Therapeutics, Inc. and the Registrant, as amended by Amendment No. 1, effective June 30, 2023
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Joint Clinical Collaboration Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated December 24, 2021
Collaboration Agreements
ArriVent Biopharma, Inc.
2024
Amended and Restated Investors Rights Agreement, dated as of December 16, 2022
Investor Rights Agreements
ArriVent Biopharma, Inc.
DE
2024
Offer Letter Agreement, by and between the Registrant and Winston Kung, MBA, dated January 3, 2024
ArriVent Biopharma, Inc.
2024
Offer Letter Agreement, by and between the Registrant and James Kastenmayer, J.D., Ph.D., dated August 11, 2023
ArriVent Biopharma, Inc.
2024
Offer Letter Agreement, by and between the Registrant and Robin LaChapelle, dated May 21, 2021
ArriVent Biopharma, Inc.
2024
Offer Letter Agreement, by and between the Registrant and Stuart Lutzker, M.D., Ph.D., dated May 1, 2021
ArriVent Biopharma, Inc.
2024
Offer Letter Agreement, by and between the Registrant and Zhengbin (Bing) Yao, Ph.D., dated May 5, 2021
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Clawback Policy
ArriVent Biopharma, Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Executive Severance Plan
Severance Agreements
ArriVent Biopharma, Inc.
DE
2024
2021 Employee, Director and Consultant Equity Incentive Plan, as amended and form of stock option agreement thereunder
Bonus & Incentive Agreements
ArriVent Biopharma, Inc.
DE
2024
Form of Indemnification Agreement
Indemnification Agreements
ArriVent Biopharma, Inc.
DE
2024